Sodium Heparin
Important Information for the Patient.
This medication should always be used exactly as described in this patient leaflet or as advised by a doctor or pharmacist.
Heparizen 1000 is a gel for topical application; it contains sodium heparin and has a local anticoagulant effect.
Sodium heparin applied externally to the skin in the form of a gel accelerates the absorption of hematomas and infiltrates.
It inhibits superficial inflammatory processes by inactivating enzymes, including hyaluronidase and phosphatase.
It has a long-lasting effect on pathologically changed tissues, relieves pain and tension, improves the metabolism of subcutaneous connective tissue due to its hydrophilic nature, shortening the duration of the disease.
Heparizen 1000 is a supportive medication in the treatment of:
It is also used in the prevention and treatment of hypertrophic scars and keloids.
Before starting to use Heparizen 1000, the patient should discuss it with their doctor or pharmacist.
Heparizen 1000 should not be applied to open, bleeding, purulent, and discharging wounds, skin lesions of unknown origin, infected skin, mucous membranes, and the eye area. Patients with bleeding disorders should exercise particular caution. The medication should be discontinued if the patient experiences: redness of the skin, rash, itching, burning, erythema.
Heparizen 1000 should not be used in children due to the lack of studies on the safety and efficacy of its use.
The patient should inform their doctor or pharmacist about all medications they are currently taking or have recently taken, as well as any medications they plan to take.
During topical use of Heparizen 1000, no interactions with other medications used in the form of a gel and applied topically to the skin have been observed. Due to the limited ability of sodium heparin to penetrate the skin, interactions with other medications are insignificant.
Only in patients who are administered oral anticoagulant medications may an enhanced effect of sodium heparin and prolonged blood clotting time occasionally occur.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before using this medication.
Sodium heparin does not cross the placenta. Heparizen 1000 can be used during pregnancy with caution, in cases of absolute necessity.
Sodium heparin does not penetrate into human milk. Heparizen 1000 can be used during breastfeeding with caution, in cases of absolute necessity.
Heparizen 1000 does not affect the ability to drive and use machines.
The medication may cause allergic reactions (possible late-type reactions).
This medication contains 47.6 mg of ethanol per gram of gel. It may cause a burning sensation on damaged skin. The medication is flammable. It should not be used near an open flame, a lit cigarette, or certain devices (e.g., hair dryers).
This medication should always be used exactly as described in this patient leaflet or as advised by a doctor or pharmacist.
In case of doubts, the patient should consult their doctor or pharmacist.
Heparizen 1000 should be applied topically to the skin.
Recommended dose
Apply the gel to the pathologically changed skin surface and the surrounding area 1 to 3 times a day.
Depending on the surface area affected by the disease, apply 5 to 10 cm of gel to the skin and gently massage for a few minutes.
There are no reports of overdose symptoms. However, if such a case occurs, the patient should contact their doctor.
The use of protamine sulfate will inactivate sodium heparin due to the formation of stable, pharmacologically inactive complexes.
A double dose should not be used to make up for a missed dose.
Like all medications, Heparizen 1000 can cause side effects, although not everybody gets them.
Prolonged use of the medication may occasionally cause skin hypersensitivity reactions: erythema, skin inflammation, itching, burning sensation, feeling of cold, dry skin, rash, redness of the skin.
If any side effects occur, including any side effects not listed in this leaflet, the patient should inform their doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help gather more information on the safety of the medication.
The medication should be stored out of sight and reach of children.
There are no special precautions for storing the medication.
Store in the original, tightly closed packaging.
Shelf life after first opening the tube: 3 years, but no longer than the expiration date stated on the packaging.
Do not use this medication after the expiration date stated on the packaging after: "EXP".
The expiration date refers to the last day of the specified month.
Medications should not be disposed of in wastewater or household waste containers. The patient should ask their pharmacist how to dispose of unused medications. This will help protect the environment.
Heparizen 1000 is a semi-solid, colorless, transparent gel.
Packaging: aluminum tube, lacquered, with a membrane and a latex ring, closed with a polyethylene cap with a puncture device, containing 30 g, 50 g, or 100 g of gel, placed in a cardboard box.
Not all pack sizes may be marketed.
ZIAJA Ltd Pharmaceutical Production Plant sp. z o.o.
ul. Jesienna 9
80-298 Gdańsk
Phone: +48 58 521 34 00
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.